Work

Abstract 17374: Reduced Risk of Hyperkalemia in Heart Failure Patients Treated With an MRA and Sacubitril/Valsartan Compared With Enalapril: The PARADIGM-HF Trial

Cites:
Cited by:
Related to: 10